| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.71B | 1.42B | 876.10M | 1.07B | 871.59M | 842.02M |
| Gross Profit | 406.83M | 351.53M | 289.04M | 213.14M | 179.67M | 201.02M |
| EBITDA | 351.81M | 299.59M | 299.04M | 230.63M | 148.25M | 154.86M |
| Net Income | 346.50M | 260.70M | 255.52M | 194.35M | 160.01M | 151.78M |
Balance Sheet | ||||||
| Total Assets | 2.92B | 2.78B | 2.61B | 2.61B | 2.46B | 2.22B |
| Cash, Cash Equivalents and Short-Term Investments | 905.13M | 277.49M | 690.65M | 997.87M | 817.01M | 576.11M |
| Total Debt | 0.00 | 0.00 | 0.00 | 130.09M | 100.06M | 0.00 |
| Total Liabilities | 182.04M | 133.76M | 80.72M | 240.40M | 238.54M | 116.57M |
| Stockholders Equity | 2.73B | 2.65B | 2.53B | 2.37B | 2.23B | 2.11B |
Cash Flow | ||||||
| Free Cash Flow | 371.14M | -271.55M | -162.67M | 185.29M | 119.31M | 158.39M |
| Operating Cash Flow | 473.83M | -109.20M | -29.85M | 240.73M | 194.02M | 211.25M |
| Investing Cash Flow | -267.84M | -52.64M | 572.42M | -377.58M | -66.22M | -334.75M |
| Financing Cash Flow | -201.68M | -144.56M | -226.59M | -33.12M | 65.09M | 43.54M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$13.25B | 15.20 | 12.70% | 1.98% | 38.54% | 49.91% | |
72 Outperform | HK$989.78M | 3.70 | 5.08% | 10.44% | -1.19% | -9.05% | |
68 Neutral | HK$2.45B | 7.35 | 13.72% | 3.74% | 11.89% | 27.80% | |
67 Neutral | HK$7.76B | 17.92 | 5.55% | 1.41% | 7.29% | -33.19% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
58 Neutral | HK$7.29B | 5.21 | 6.29% | ― | 100.45% | 2.89% |
Yantai North Andre Juice Co., Ltd. has completed a substantial repurchase and cancellation of its H shares under a general mandate approved at its 2024 annual general meeting. Between June and late December 2025, the company executed 21 repurchase transactions, buying back an aggregate 7,012,000 H shares for a total consideration of HK$121.8 million, equal to about 9.92% of its issued H shares and 2.06% of total share capital at the time the mandate was granted. These repurchased shares were formally cancelled on 30 December 2025, reducing total share capital from 341.2 million to 334.188 million shares and decreasing the proportion of H shares from 20.71% to 19.05%, while A shares rose proportionally to 80.95%. The move tightens the company’s share base and may enhance per‑share metrics, while slightly shifting the ownership structure away from Hong Kong-listed H shares toward its domestic A shares.